Dr. Gregory Motz is a 2011 Ann Schreiber Program of Excellence Grantee. In this interview with OCRF's Sarah DeFeo, Dr. Motz discusses his research, what motivated him to focus his efforts on ovarian cancer research, and what it means to receive a grant from OCRF.
Dr. Ruth Perets is a 2011 Ann Schreiber Program of Excellence Grant Recipient. Her research is funded in part thanks to the support of The National Ovarian Cancer Coalition.
Dr. Jeff Boyd is Senior Vice President and Chief Scientific Officer of the Fox Chase Cancer Center in Philadelphia, PA. In November 2009 he was appointed Chair of OCRF's Scientific Advisory Committee. In this interview with OCRF's Sarah DeFeo, Dr. Boyd shares his thoughts on the most promising areas of ovarian cancer research, and how OCRF is uniquely positioned to make a real impact on the disease.
Kathryn Terry, ScD is an Assistant Professor of Obstetrics, Gynecology, and Reproductive Biology att he Harvard Medical School/Brigham and Women's Hospital in Boston, MA. She received an OCRF Liz Tilberis award in both 2006 and 2009. She was interviewed by OCRF's Director of Grants, Sarah DeFeo.
Dr. Mitchell Ho is a Principal Investigator and Head of the Antibody Therapy Unit in the Laboratory of Molecular Biology at the National Cancer Institute. He is a 2007 recipient of OCRF's Individual Investigator Award
Dr. Tian-Li Wang is an Assistant Professor in the Department of Obstetrics and Gynecology at the Johns Hopkins Medical Institution in Baltimore, Maryland. She is the recipient of an OCRF Individual Investigator Award.
Dr. Gary Leiserowitz is a Professor, and Chief of the Division of Gynecologic Oncology at the University of California, Davis Medical Center. He is a 2008 recipient of OCRF's largest and most prestigious grant, the Program Project Development Grant.
Dr. Ernst Lengyel, as Associate Professor of Gynecologic Oncology at the University of Chicago, is a recipient of OCRF's Liz Tilberis Award. He was interviewed by OCRF's CEO Elizabeth Howard.
Dr. Barbara Goff was recently interviewed by OCRF's CEO Elizabeth Howard about her work on her ovarian cancer symptoms study.
This is the first in a series of interviews conducted by OCRF's Chief Executive Officer, Elizabeth Howard.
He was interviewed on May 26, 2009, by OCRF's Chief Executive Officer, Elizabeth Howard.
She was interviewed by OCRF's CEO Elizabeth Howard on June 2nd.
Get email updates about research news, action alerts, and ways to join the fight.
